
Hubert C. Lorin
Examiner (ID: 8123)
| Most Active Art Unit | 1307 |
| Art Unit(s) | 1307, 2899 |
| Total Applications | 717 |
| Issued Applications | 500 |
| Pending Applications | 0 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5457936
[patent_doc_number] => 20090258088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY'
[patent_app_type] => utility
[patent_app_number] => 12/311949
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3973
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258088.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311949 | USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY | Oct 23, 2007 | Abandoned |
Array
(
[id] => 6134543
[patent_doc_number] => 20110008445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SUSPENSION OF ASCORBIC ACID IN GLYCERIN AND PROCESS FOR PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/445775
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4477
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445775
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445775 | Suspension of ascorbic acid in glycerin and process for production thereof | Oct 17, 2007 | Issued |
Array
(
[id] => 6389183
[patent_doc_number] => 20100317745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Bioresorbable Polymers'
[patent_app_type] => utility
[patent_app_number] => 12/446235
[patent_app_country] => US
[patent_app_date] => 2007-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8083
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317745.pdf
[firstpage_image] =>[orig_patent_app_number] => 12446235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446235 | Bioresorbable polymers | Oct 14, 2007 | Issued |
Array
(
[id] => 6466682
[patent_doc_number] => 20100040566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'EMULSION'
[patent_app_type] => utility
[patent_app_number] => 12/441882
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18799
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441882
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441882 | EMULSION | Sep 26, 2007 | Abandoned |
Array
(
[id] => 7770257
[patent_doc_number] => 08118028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Intrauterine contraceptive device'
[patent_app_type] => utility
[patent_app_number] => 12/311152
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2331
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/118/08118028.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311152
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311152 | Intrauterine contraceptive device | Sep 19, 2007 | Issued |
Array
(
[id] => 6599781
[patent_doc_number] => 20100292272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'SUPRAMOLECULAR CO-COLLOIDS PRODUCED USING MACROCYCLIC POLYANIONIC SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 12/377065
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6108
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377065
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377065 | SUPRAMOLECULAR CO-COLLOIDS PRODUCED USING MACROCYCLIC POLYANIONIC SYSTEMS | Aug 9, 2007 | Abandoned |
Array
(
[id] => 6617569
[patent_doc_number] => 20100003309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'METHOD FOR THE PRODUCTION OF FENTANYL-BASED ANESTHETICS FOR THEIR ORAL TRANSMUCOSAL ADMINISTRATION IN A CANDY-LIKE DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 12/373195
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1625
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003309.pdf
[firstpage_image] =>[orig_patent_app_number] => 12373195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373195 | METHOD FOR THE PRODUCTION OF FENTANYL-BASED ANESTHETICS FOR THEIR ORAL TRANSMUCOSAL ADMINISTRATION IN A CANDY-LIKE DOSAGE FORM | Jul 10, 2007 | Abandoned |
Array
(
[id] => 8188364
[patent_doc_number] => 08182825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Message energy memory ceramics'
[patent_app_type] => utility
[patent_app_number] => 11/762054
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 2273
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182825.pdf
[firstpage_image] =>[orig_patent_app_number] => 11762054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/762054 | Message energy memory ceramics | Jun 11, 2007 | Issued |
Array
(
[id] => 9495514
[patent_doc_number] => 08734325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Oxygen therapy with ultrasound'
[patent_app_type] => utility
[patent_app_number] => 11/759284
[patent_app_country] => US
[patent_app_date] => 2007-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4372
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11759284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/759284 | Oxygen therapy with ultrasound | Jun 6, 2007 | Issued |
Array
(
[id] => 8445859
[patent_doc_number] => 08287908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Preparation of molecular imprinted polymers'
[patent_app_type] => utility
[patent_app_number] => 12/279238
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 11866
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12279238
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279238 | Preparation of molecular imprinted polymers | Feb 20, 2007 | Issued |
Array
(
[id] => 7773091
[patent_doc_number] => 08119163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Nanoparticulate and controlled release compositions comprising cefditoren'
[patent_app_type] => utility
[patent_app_number] => 11/671276
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19490
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11671276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/671276 | Nanoparticulate and controlled release compositions comprising cefditoren | Feb 4, 2007 | Issued |
Array
(
[id] => 4834444
[patent_doc_number] => 20080132991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Method for Ionically Cross-Linking Gellan Gum for Thin Film Applications and Medical Devices Produced Therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/565065
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4956
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565065 | Method for Ionically Cross-Linking Gellan Gum for Thin Film Applications and Medical Devices Produced Therefrom | Nov 29, 2006 | Abandoned |
Array
(
[id] => 9238704
[patent_doc_number] => 08603493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Carbosilane dendrimers, preparation method thereof and use of same'
[patent_app_type] => utility
[patent_app_number] => 11/989157
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 50
[patent_no_of_words] => 44111
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11989157
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989157 | Carbosilane dendrimers, preparation method thereof and use of same | Jul 20, 2006 | Issued |
Array
(
[id] => 5302944
[patent_doc_number] => 20090297596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/568835
[patent_app_country] => US
[patent_app_date] => 2006-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19829
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297596.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568835 | Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor | May 22, 2006 | Abandoned |
Array
(
[id] => 8943777
[patent_doc_number] => 08496953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => 'Immobilized biologically active entities having a high degree of biological activity following sterilization'
[patent_app_type] => utility
[patent_app_number] => 11/433105
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 11276
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11433105
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433105 | Immobilized biologically active entities having a high degree of biological activity following sterilization | May 11, 2006 | Issued |
Array
(
[id] => 9354819
[patent_doc_number] => 08673351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Crystallization inhibitor and its use in gelatin capsules'
[patent_app_type] => utility
[patent_app_number] => 11/886500
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3491
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11886500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886500 | Crystallization inhibitor and its use in gelatin capsules | Mar 15, 2006 | Issued |
Array
(
[id] => 8374949
[patent_doc_number] => 08257742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Bisphosphonates for treating endometriosis'
[patent_app_type] => utility
[patent_app_number] => 11/816245
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7886
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816245 | Bisphosphonates for treating endometriosis | Feb 15, 2006 | Issued |
Array
(
[id] => 5677446
[patent_doc_number] => 20060182801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Sequestered antagonist formulations'
[patent_app_type] => utility
[patent_app_number] => 11/352900
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27563
[patent_no_of_claims] => 157
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352900 | Sequestered antagonist formulations | Feb 12, 2006 | Issued |
Array
(
[id] => 5672143
[patent_doc_number] => 20060177497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention'
[patent_app_type] => utility
[patent_app_number] => 10/565593
[patent_app_country] => US
[patent_app_date] => 2006-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3992
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565593
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565593 | Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention | Jan 22, 2006 | Abandoned |
Array
(
[id] => 5693748
[patent_doc_number] => 20060153895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Drug-containing implants and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/183232
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29127
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183232 | Drug-containing implants and methods of use thereof | Jul 17, 2005 | Issued |